药物对比
Lasmiditan vs Methysergide
比较 Lasmiditan (Reyvow) 与 Methysergide 用于偏头痛：前者为急性 5‑HT1F 治疗，后者为较旧的预防药物，存在纤维化风险。使用和安全性方面的主要差异。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when evaluating acute migraine abortive therapy against historical prophylactic options in patients with frequent attacks.
结论
Lasmiditan is the preferred option for acute treatment while Methysergide is obsolete for prevention due to safety concerns.
全部药物对比